QQQ $ 474.45 $ 1.02 (0.22 %)
DIA $ 414.68 $ 2.05 (0.5 %)
SPY $ 561.41 $ 1.14 (0.2 %)
TLT $ 100.47 $ -0.01 (-0.01 %)
GLD $ 238.63 $ 1.04 (0.44 %)
$ 1.55
-- x --
-- x --
-- - --
$ 0.78 - $ 2.60
625
na
6.82M
$ 2.23
$ 2.43
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-27-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 04-01-2021 12-31-2020 10-K
16 01-20-2021 09-30-2020 10-Q
17 10-19-2020 06-30-2020 10-Q
18 06-26-2020 03-31-2020 10-Q
19 04-22-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-21-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-23-2018 12-31-2017 10-K
28 11-13-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-31-2017 12-31-2016 10-K
32 11-17-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-12-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-14-2015 06-30-2015 10-Q
38 05-12-2015 03-31-2015 10-Q
39 03-05-2015 12-31-2014 10-K
40 11-05-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-downgrades-interpace-biosciences-to-neutral

HC Wainwright & Co. analyst Yi Chen downgrades Interpace Biosciences (OTC:IDXG) from Buy to Neutral.

 interpace-diagnostics-gr-q1-adj-ebitda-loss-900k-vs-loss-43m-in-same-qtr-last-year-sales-980m-up-from-920m-yoy

Interpace Diagnostics Gr (NASDAQ:IDXG) reported $9.80 million in sales this quarter. This is a 6.52 percent increase over sales...

 interpace-pharma-solutions-highlights-new-rnascope-ish-product

Interpace Pharma Solutions, a subsidiary of Interpace Biosciences, Inc. ("Interpace" or the "Company") (OTCQX:I...

 hc-wainwright--co-maintains-buy-on-interpace-biosciences-raises-price-target-to-9

HC Wainwright & Co. analyst Yi Chen maintains Interpace Biosciences (OTC:IDXG) with a Buy and raises the price target fr...

 interpace-biosciences-reports-expansion-of-relationship-with-xifin-to-deploy-revenue-cycle-mgmt-solution

Interpace Biosciences, Inc., a leader in molecular testing for cancer risk, today announced that it has expanded its relationsh...

 92-biggest-movers-from-yesterday
92 Biggest Movers From Yesterday
02/18/2021 10:07:42

Gainers

Core News & Articles

Gainers TDH Holdings, Inc. (NASDAQ: PETZ) shares climbed 302% to $12.58 after jumping more than 25% on Tuesday.

 interpace-biosciences-announces-impending-delisting-from-nasdaq-will-be-suspended-at-opening-of-business-feb-25-2021

Interpace Biosciences Announces Impending Delisting from Nasdaq PARSIPPANY, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Interpace Bi...

 interpace-biosciences-announces-license-agreement-with-rutgers-university-mass-general-hospital

Interpace Biosciences Announces License Agreement with Rutgers University and Mass General Hospital Parsippany, NJ, Feb. 01, 2...

 hc-wainwright--co-maintains-buy-on-interpace-biosciences-lowers-price-target-to-6

HC Wainwright & Co. analyst Yi Chen maintains Interpace Biosciences (NASDAQ:IDXG) with a Buy and lowers the price target...

 interpace-diagnostics-gr-q3-eps-154-down-from-019-yoy-sales-820m-up-from-772m-yoy

Interpace Diagnostics Gr (NASDAQ:IDXG) reported quarterly losses of $(1.54) per share. This is a 710.53 percent decrease over l...

Core News & Articles

Gainers

Core News & Articles

Gainers Panbela Therapeutics (NASDAQ:PBLA) shares moved upwards by 145.5% to $10.52 during Wednesday's after-market sessio...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION